Logo image of KNW

KNOW LABS INC (KNW) Stock Fundamental Analysis

NYSEARCA:KNW - NYSE Arca - US4992382022 - Common Stock - Currency: USD

0.5112  +0.01 (+2.24%)

After market: 0.5 -0.01 (-2.19%)

Fundamental Rating

0

Overall KNW gets a fundamental rating of 0 out of 10. We evaluated KNW against 189 industry peers in the Health Care Equipment & Supplies industry. KNW has a bad profitability rating. Also its financial health evaluation is rather negative. KNW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KNW had negative earnings in the past year.
In the past year KNW has reported a negative cash flow from operations.
KNW had negative earnings in each of the past 5 years.
In the past 5 years KNW always reported negative operating cash flow.
KNW Yearly Net Income VS EBIT VS OCF VS FCFKNW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

KNW has a Return On Assets of -1168.61%. This is amonst the worse of the industry: KNW underperforms 98.94% of its industry peers.
Industry RankSector Rank
ROA -1168.61%
ROE N/A
ROIC N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KNW Yearly ROA, ROE, ROICKNW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KNW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KNW Yearly Profit, Operating, Gross MarginsKNW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for KNW has been increased compared to 1 year ago.
KNW has a worse debt/assets ratio than last year.
KNW Yearly Shares OutstandingKNW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
KNW Yearly Total Debt VS Total AssetsKNW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -163.81, we must say that KNW is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -163.81, KNW is doing worse than 96.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -163.81
ROIC/WACCN/A
WACCN/A
KNW Yearly LT Debt VS Equity VS FCFKNW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 0.20 indicates that KNW may have some problems paying its short term obligations.
KNW has a worse Current ratio (0.20) than 96.30% of its industry peers.
A Quick Ratio of 0.20 indicates that KNW may have some problems paying its short term obligations.
With a Quick ratio value of 0.20, KNW is not doing good in the industry: 95.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
KNW Yearly Current Assets VS Current LiabilitesKNW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.65% over the past year.
KNW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)47.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4900%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 1.18% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KNW Yearly Revenue VS EstimatesKNW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2026 2M 4M 6M
KNW Yearly EPS VS EstimatesKNW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KNW. In the last year negative earnings were reported.
Also next year KNW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KNW Price Earnings VS Forward Price EarningsKNW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KNW Per share dataKNW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y1.18%

More info and screens

0

5. Dividend

5.1 Amount

KNW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNOW LABS INC

NYSEARCA:KNW (5/21/2025, 8:11:42 PM)

After market: 0.5 -0.01 (-2.19%)

0.5112

+0.01 (+2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-20 2025-05-20
Earnings (Next)08-12 2025-08-12
Inst Owners5.52%
Inst Owner ChangeN/A
Ins Owners18.59%
Ins Owner Change1.29%
Market Cap1.44M
Analysts80
Price Target40.8 (7881.22%)
Short Float %18.33%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.89%
Min EPS beat(2)0.99%
Max EPS beat(2)20.79%
EPS beat(4)3
Avg EPS beat(4)0.17%
Min EPS beat(4)-38.61%
Max EPS beat(4)20.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3900%
EPS NY rev (1m)0%
EPS NY rev (3m)-3900%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.4
EYN/A
EPS(NY)-9.29
Fwd EYN/A
FCF(TTM)-4.05
FCFYN/A
OCF(TTM)-4.03
OCFYN/A
SpS0
BVpS-1.39
TBVpS-1.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1168.61%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.48%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z -163.81
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)147.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4900%
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.63%
OCF growth 3YN/A
OCF growth 5YN/A